Quick Answer
RELMADA THERAPEUTICS, INC. reported Stockholders Equity of $86.51 million for the year ending 2025.
- RELMADA THERAPEUTICS, INC. showed an increase of +143.5% in Stockholders Equity from 2024 to 2025.
- This data is from RELMADA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: $13.84 million | Q4 2015: $11.76 million | Q1 2016: $10.20 million | Q3 2016: $5.57 million | Q4 2016: $4.67 million | Q1 2017: $2.80 million | Q3 2017: $1.46 million | Q4 2017: $721.2 thousand | Q1 2018: -$2.32 million | Q3 2018: -$8.68 million | Q4 2018: $1.43 million | Q1 2019: $473.9 thousand | Q3 2019: $5.98 million | Q1 2020: $113.16 million | Q2 2020: $132.23 million | Q3 2020: $122.21 million | Q1 2021: $91.15 million | Q2 2021: $96.85 million | Q3 2021: $72.69 million | Q1 2022: $210.40 million | Q2 2022: $196.85 million | Q3 2022: $166.34 million | Q1 2023: $125.47 million | Q2 2023: $111.34 million | Q3 2023: $100.73 million | Q1 2024: $72.05 million | Q2 2024: $61.49 million | Q3 2024: $47.63 million | Q1 2025: $22.44 million | Q2 2025: $15.95 million | Q3 2025: $9.47 million.
- Over the full 18 years of available data (2011 to 2025), RELMADA THERAPEUTICS, INC.'s Stockholders Equity has grown by 872,876.9%.
- Historical annual values: Fiscal year 2025: $86.51 million | Fiscal year 2024: $35.52 million | Fiscal year 2023: $85.36 million | Fiscal year 2022: $140.44 million | Fiscal year 2021: $208.26 million | Fiscal year 2020: $105.58 million | Fiscal year 2019: $115.68 million | Fiscal year 2019: $7.61 million | Fiscal year 2018: -$5.51 million | Fiscal year 2017: $1.46 million | Fiscal year 2016: $7.04 million | Fiscal year 2015: $8.81 million | Fiscal year 2014: -$1.11 million | Fiscal year 2013: -$17.95 million | Fiscal year 2013: -$13.7 thousand | Fiscal year 2012: -$3.71 million | Fiscal year 2012: $11.4 thousand | Fiscal year 2011: $9.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: